AbstractBackgroundAlthough partial splenic embolization (PSE) has been widely used for treatment of leucocytopaenia and thrombocytopaenia in cirrhosis, only few studies evaluate both benefits and complications of it.ObjectiveTo evaluate outcome of partial splenic embolization benefits on both platelet and leukocytes counts and its complications in treatment of cirrhotic patients.Patients and methodsCirrhotic patients with hypersplenism-induced thrombo-cytopenia underwent partial splenic embolization (PSE). From All patients complete history and full clinical examination were taken and subjected to Laboratory investigations. After PSE was performed, the precise extent of embolization was calculated on CT examinations 2weeks after PSE. Prophy...
Purpose: Partial splenic endovascular embolization (PSEE) could be an option for patients with throm...
Objective This study was performed to investigate the efficacy of proximal splenic artery embolizati...
Hypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due ...
AbstractBackgroundAlthough partial splenic embolization (PSE) has been widely used for treatment of ...
AIM To determine the outcomes of partial splenic embolization (PSE) for massive splenomegaly due to ...
AbstractObjectiveTo discover the effect of partial splenic embolization on the immune function of ci...
Since the early 1970s several studies have reported distal splenic artery embolization, better known...
AbstractPurposeThe objective of this retrospective study was to analyze the efficacy and morbidity a...
AbstractPurposeTo evaluate the ability of interval spaced sessions of transcatheter partial splenic ...
ObjectiveTo investigate the clinical efficacy and therapeutic value of partial splenic artery emboli...
Antiviral therapy in hepatitis C virus (HCV) infection is limited by haematological side-effects, es...
Purpose. Restoration of the balance between T lymphocyte subsets and between Th1/Th2 cytokines toget...
Hepatocellular carcinoma (HCC) is frequently complicated by cirrhosis, and it is not unusual for tre...
Copyright © 2014 Yoshihiko Ooka et al.This is an open access article distributed under theCreative C...
Background. Both splenectomy (SP) and partial splenic embolization (PSE) are used to treat massive s...
Purpose: Partial splenic endovascular embolization (PSEE) could be an option for patients with throm...
Objective This study was performed to investigate the efficacy of proximal splenic artery embolizati...
Hypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due ...
AbstractBackgroundAlthough partial splenic embolization (PSE) has been widely used for treatment of ...
AIM To determine the outcomes of partial splenic embolization (PSE) for massive splenomegaly due to ...
AbstractObjectiveTo discover the effect of partial splenic embolization on the immune function of ci...
Since the early 1970s several studies have reported distal splenic artery embolization, better known...
AbstractPurposeThe objective of this retrospective study was to analyze the efficacy and morbidity a...
AbstractPurposeTo evaluate the ability of interval spaced sessions of transcatheter partial splenic ...
ObjectiveTo investigate the clinical efficacy and therapeutic value of partial splenic artery emboli...
Antiviral therapy in hepatitis C virus (HCV) infection is limited by haematological side-effects, es...
Purpose. Restoration of the balance between T lymphocyte subsets and between Th1/Th2 cytokines toget...
Hepatocellular carcinoma (HCC) is frequently complicated by cirrhosis, and it is not unusual for tre...
Copyright © 2014 Yoshihiko Ooka et al.This is an open access article distributed under theCreative C...
Background. Both splenectomy (SP) and partial splenic embolization (PSE) are used to treat massive s...
Purpose: Partial splenic endovascular embolization (PSEE) could be an option for patients with throm...
Objective This study was performed to investigate the efficacy of proximal splenic artery embolizati...
Hypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due ...